Release date: 31 July 2018
Promoter – Financial Intermediary
JENNEWEIN BIOTECHNOLOGIE GMBHLocation
Description
Jennewein is a highly innovative German biotechnology food company focused on novel production processes for the synthesis of human milk oligosaccharides (functional nutritive sugars) for a wide range of applications, including nutritional, pharmaceutical and cosmetic products.
Objectives
The project will cover research and development (R&D) costs, both operational expenditure (OPEX) and capital expenditure (CAPEX) related to the up-scaling of the production of the human milk oligosaccharides, clinical trials for the new products and related R&D activities.
Sector(s)
- Services - Professional, scientific and technical activities
Proposed EIB finance (Approximate amount)
EUR 15 million
Total cost (Approximate amount)
EUR 40 million
Environmental aspects
The project mainly concerns investments in R&D that are expected to be carried out in existing facilities already authorised for the same purpose and would therefore not require an environmental impact assessment (EIA) under the Directive 2011/92/EU. Full environmental details will be verified during the appraisal.
Procurement
The promoter is a private company, not operating in the utilities sector and does not have the status of a contracting authority; thus the project is not subject to the EU directives on procurement.
Status
Signed - 20/07/2018
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).